Pages that link to "Q35835236"
Jump to navigation
Jump to search
The following pages link to Disease- and age-related changes in histone acetylation at gene promoters in psychiatric disorders (Q35835236):
Displaying 44 items.
- Continuous Aging of the Human DNA Methylome Throughout the Human Lifespan (Q21133004) (← links)
- Transcriptional regulation of GAD1 GABA synthesis gene in the prefrontal cortex of subjects with schizophrenia (Q26991794) (← links)
- REM sleep and its Loss-Associated Epigenetic Regulation with Reference to Noradrenaline in Particular (Q28073069) (← links)
- Dissecting bipolar disorder complexity through epigenomic approach (Q28076508) (← links)
- Rethinking the Epigenetic Framework to Unravel the Molecular Pathology of Schizophrenia (Q33624604) (← links)
- Expression of HDAC2 but Not HDAC1 Transcript Is Reduced in Dorsolateral Prefrontal Cortex of Patients with Schizophrenia. (Q33703849) (← links)
- Histone acetylation: molecular mnemonics on the chromatin. (Q34322979) (← links)
- Epigenetic mechanisms in schizophrenia. (Q34426222) (← links)
- Histone Posttranslational Modifications in Schizophrenia (Q34682060) (← links)
- BDNF promoter methylation and genetic variation in late-life depression (Q36043366) (← links)
- Interneuron epigenomes during the critical period of cortical plasticity: Implications for schizophrenia. (Q36055182) (← links)
- Epigenetics in the human brain (Q36465858) (← links)
- Markedly Lower Glutamic Acid Decarboxylase 67 Protein Levels in a Subset of Boutons in Schizophrenia (Q36554729) (← links)
- DNA methylation in schizophrenia: progress and challenges of epigenetic studies (Q36632924) (← links)
- The future of neuroepigenetics in the human brain. (Q36891239) (← links)
- Conserved chromosome 2q31 conformations are associated with transcriptional regulation of GAD1 GABA synthesis enzyme and altered in prefrontal cortex of subjects with schizophrenia. (Q37020191) (← links)
- An epigenomics approach to individual differences and its translation to neuropsychiatric conditions (Q37344769) (← links)
- The genome in three dimensions: a new frontier in human brain research (Q37587078) (← links)
- Epigenetic determinants of healthy and diseased brain aging and cognition (Q37598709) (← links)
- Histone deacetylase 2 in the mouse hippocampus: attenuation of age-related increase by caloric restriction (Q37665547) (← links)
- HDAC inhibitors restore the capacity of aged mice to respond to haloperidol through modulation of histone acetylation (Q37705756) (← links)
- Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors (Q38079160) (← links)
- Targeting specific HATs for neurodegenerative disease treatment: translating basic biology to therapeutic possibilities (Q38094663) (← links)
- Epigenetic approaches for bipolar disorder drug discovery (Q38215889) (← links)
- Transcriptome sequencing implicates dorsal striatum-specific gene network, immune response and energy metabolism pathways in bipolar disorder (Q38437361) (← links)
- An update on the epigenetics of psychotic diseases and autism (Q38528430) (← links)
- Epigenetic Basis of Mental Illness (Q38602855) (← links)
- Two-stage additional evidence support association of common variants in the HDAC3 with the increasing risk of schizophrenia susceptibility (Q47950519) (← links)
- Neuregulin-1 alpha, the underestimated molecule: emerging new roles in normal brain function and the pathophysiology of schizophrenia? (Q48828753) (← links)
- Histone deacetylase inhibitors reverse age-related increases in side effects of haloperidol in mice (Q50656271) (← links)
- Into the Fourth Dimension: Dysregulation of Genome Architecture in Aging and Alzheimer's Disease (Q51763074) (← links)
- Systemic Biomarkers of Accelerated Aging in Schizophrenia: A Critical Review and Future Directions. (Q51768375) (← links)
- Studies on Prostaglandin-Endoperoxide Synthase 1: Lower Levels in Schizophrenia and After Treatment with Antipsychotic Drugs in Conjunction with Aspirin. (Q55215406) (← links)
- A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme (Q57811369) (← links)
- Preterm Birth and the Risk of Neurodevelopmental Disorders - Is There a Role for Epigenetic Dysregulation? (Q58549228) (← links)
- Genomics: New Light on Alzheimer's Disease Research (Q60935279) (← links)
- Epigenetic Alterations Impact on Antipsychotic Treatment in Elderly Patients (Q88656413) (← links)
- From Schizophrenia Genetics to Disease Biology: Harnessing New Concepts and Technologies (Q90294273) (← links)
- PET neuroimaging reveals histone deacetylase dysregulation in schizophrenia (Q90366883) (← links)
- Apolipoprotein E-ε4 allele predicts escalation of psychotic symptoms in late adulthood (Q90744462) (← links)
- Histone deacetylase 4 (HDAC4): a new player in anorexia nervosa? (Q91450885) (← links)
- From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs (Q92334161) (← links)
- Epigenetic mechanisms in schizophrenia and other psychotic disorders: a systematic review of empirical human findings (Q92453407) (← links)
- Novel Treatment Strategies Targeting Myelin and Oligodendrocyte Dysfunction in Schizophrenia (Q95270886) (← links)